Literature DB >> 24569139

Selective evaluation of high density lipoprotein from mouse small intestine by an in situ perfusion technique.

Satoshi Yamaguchi1, Bo Zhang, Takeshi Tomonaga, Utako Seino, Akiko Kanagawa, Masaru Segawa, Hironori Nagasaka, Akira Suzuki, Takashi Miida, Sohsuke Yamada, Yasuyuki Sasaguri, Takefumi Doi, Keijiro Saku, Mitsuyo Okazaki, Yoshihiro Tochino, Ken-Ichi Hirano.   

Abstract

The small intestine (SI) is the second-greatest source of HDL in mice. However, the selective evaluation of SI-derived HDL (SI-HDL) has been difficult because even the origin of HDL obtained in vivo from the intestinal lymph duct of anesthetized rodents is doubtful. To shed light on this question, we have developed a novel in situ perfusion technique using surgically isolated mouse SI, with which the possible filtration of plasma HDL into the SI lymph duct can be prevented. With the developed method, we studied the characteristics of and mechanism for the production and regulation of SI-HDL. Nascent HDL particles were detected in SI lymph perfusates in WT mice, but not in ABCA1 KO mice. SI-HDL had a high protein content and was smaller than plasma HDL. SI-HDL was rich in TG and apo AIV compared with HDL in liver perfusates. SI-HDL was increased by high-fat diets and reduced in apo E KO mice. In conclusion, with our in situ perfusion model that enables the selective evaluation of SI-HDL, we demonstrated that ABCA1 plays an important role in intestinal HDL production, and SI-HDL is small, dense, rich in apo AIV, and regulated by nutritional and genetic factors.

Entities:  

Keywords:  atherosclerosis; in situ perfusion; intestine; lipoprotein; regulation

Mesh:

Substances:

Year:  2014        PMID: 24569139      PMCID: PMC3995468          DOI: 10.1194/jlr.M047761

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  64 in total

Review 1.  Raising high density lipoprotein cholesterol. The biochemical pharmacology of reverse cholesterol transport.

Authors:  N E Miller
Journal:  Biochem Pharmacol       Date:  1990-08-01       Impact factor: 5.858

2.  Contribution of plasma protein and lipoproteins to intestinal lymph: comparison of long-chain with medium-chain triglyceride duodenal infusion.

Authors:  A M Sipahi; H C Oliveira; K S Vasconcelos; L N Castilho; A Bettarello; E C Quintão
Journal:  Lymphology       Date:  1989-03       Impact factor: 1.286

3.  Intestinal specific LXR activation stimulates reverse cholesterol transport and protects from atherosclerosis.

Authors:  Giuseppe Lo Sasso; Stefania Murzilli; Lorena Salvatore; Ilenia D'Errico; Michele Petruzzelli; Paola Conca; Zhao-Yan Jiang; Laura Calabresi; Paolo Parini; Antonio Moschetta
Journal:  Cell Metab       Date:  2010-08-04       Impact factor: 27.287

4.  Lecithin:cholesterol acyltransferase-mediated modification of discoidal peripheral lymph high density lipoproteins: possible mechanism of formation of cholesterol-induced high density lipoproteins (HDLc) in cholesterol-fed dogs.

Authors:  L Dory; C H Sloop; L M Boquet; R L Hamilton; P S Roheim
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

5.  Targeted disruption of the mouse apobec-1 gene abolishes apolipoprotein B mRNA editing and eliminates apolipoprotein B48.

Authors:  K Hirano; S G Young; R V Farese; J Ng; E Sande; C Warburton; L M Powell-Braxton; N O Davidson
Journal:  J Biol Chem       Date:  1996-04-26       Impact factor: 5.157

6.  Origin of intestinal lymph cholesterol in rats: contribution from luminal absorption, mucosal synthesis and filtration from plasma.

Authors:  K S Vasconcelos; A M Sipahi; H C Oliveira; L N Castilho; N De Luccia; E C Quintão
Journal:  Lymphology       Date:  1989-03       Impact factor: 1.286

7.  Protection against atherogenesis in mice mediated by human apolipoprotein A-IV.

Authors:  N Duverger; G Tremp; J M Caillaud; F Emmanuel; G Castro; J C Fruchart; A Steinmetz; P Denèfle
Journal:  Science       Date:  1996-08-16       Impact factor: 47.728

8.  Atherosclerotic disease in marked hyperalphalipoproteinemia. Combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase.

Authors:  K Hirano; S Yamashita; Y Kuga; N Sakai; S Nozaki; S Kihara; T Arai; K Yanagi; S Takami; M Menju
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-11       Impact factor: 8.311

9.  Characterization of apoA-IV-containing lipoprotein particles isolated from human plasma and interstitial fluid.

Authors:  N Duverger; N Ghalim; G Ailhaud; A Steinmetz; J C Fruchart; G Castro
Journal:  Arterioscler Thromb       Date:  1993-01

10.  Distribution of apolipoprotein A-IV in human plasma.

Authors:  C L Bisgaier; O P Sachdev; L Megna; R M Glickman
Journal:  J Lipid Res       Date:  1985-01       Impact factor: 5.922

View more
  4 in total

1.  Multiple apolipoprotein kinetics measured in human HDL by high-resolution/accurate mass parallel reaction monitoring.

Authors:  Sasha A Singh; Allison B Andraski; Brett Pieper; Wilson Goh; Carlos O Mendivil; Frank M Sacks; Masanori Aikawa
Journal:  J Lipid Res       Date:  2016-02-09       Impact factor: 5.922

2.  Treatment of low HDL-C subjects with the CETP modulator dalcetrapib increases plasma campesterol only in those without ABCA1 and/or ApoA1 mutations.

Authors:  Eric J Niesor; David Kallend; Darren Bentley; John J P Kastelein; G Kees Hovingh; Erik S G Stroes
Journal:  Lipids       Date:  2014-10-04       Impact factor: 1.880

3.  Dietary fat and carbohydrate modulate the effect of the ATP-binding cassette A1 (ABCA1) R230C variant on metabolic risk parameters in premenopausal women from the Genetics of Atherosclerotic Disease (GEA) Study.

Authors:  Leonor Jacobo-Albavera; Carlos Posadas-Romero; Gilberto Vargas-Alarcón; Sandra Romero-Hidalgo; Rosalinda Posadas-Sánchez; María Del Carmen González-Salazar; Alessandra Carnevale; Samuel Canizales-Quinteros; Aida Medina-Urrutia; Erika Antúnez-Argüelles; Teresa Villarreal-Molina
Journal:  Nutr Metab (Lond)       Date:  2015-11-16       Impact factor: 4.169

4.  Isolation of HDL by sequential flotation ultracentrifugation followed by size exclusion chromatography reveals size-based enrichment of HDL-associated proteins.

Authors:  Jack Jingyuan Zheng; Joanne K Agus; Brian V Hong; Xinyu Tang; Christopher H Rhodes; Hannah E Houts; Chenghao Zhu; Jea Woo Kang; Maurice Wong; Yixuan Xie; Carlito B Lebrilla; Emily Mallick; Kenneth W Witwer; Angela M Zivkovic
Journal:  Sci Rep       Date:  2021-08-09       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.